Hypoxia-mediated activation of hypoxia-inducible factor-1α in triple-negative breast cancer: A review

被引：5
作者：
Liu, Lihui [1 ,2 ]
Bai, Jie [2 ]
Hu, Lanxin [3 ]
Jiang, Daqing [2 ]
机构：
[1] Liaoning Univ Tradit Chinese Med, Shenyang, Peoples R China
[2] Dalian Univ Technol, China Med Univ, Liaoning Canc Hosp Inst, Dept Breast Surg,Canc Hosp, Shenyang 110801, Peoples R China
[3] Southwest Med Univ, Affiliated Tradit Chinese Med Hosp, Luzhou, Peoples R China
来源：
MEDICINE | 2023年 / 102卷 / 43期
关键词：
HIF-1; alpha; hypoxia; signaling pathways; TNBC; HIF-1-ALPHA; PATHWAY; PROTEIN; SITES; CELLS; STAT3; DNA;
D O I：
10.1097/MD.0000000000035493
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Triple-negative breast cancer (TNBC) is a subtype of breast cancer (BC) that is highly aggressive and hypoxic compared with other subtypes. The role of hypoxia-inducible factor 1 alpha (HIF-1 alpha) as a key hypoxic transcription factor in oncogenic processes has been extensively studied. Recently, it has been shown that HIF-1 alpha regulates the complex biological processes of TNBC, such as glycolysis, angiogenesis, invasion and metastasis, BC stem cells enrichment, and immune escape, to promote TNBC survival and development through the activation of downstream target genes. This article discusses the expression of the HIF-1 alpha transcription factor in TNBC and the Hypoxia-mediated activation of hypoxia-inducible factor-1 alpha in triple-negative BC. It offers a fresh approach to clinical research and treatment for TNBC.
引用
收藏
页数：7
相关论文
共 74 条
[61]   Combination strategy targeting the hypoxia inducible factor-1α with mammalian target of rapamycin and histone deacetylase inhibitors [J].
Verheul, Henk M. W. ;
Salumbides, Brenda ;
Van Erp, Karen ;
Hammers, Hans ;
Qian, David Z. ;
Sanni, Tolib ;
Atadja, Peter ;
Pili, Roberto .
CLINICAL CANCER RESEARCH, 2008, 14 (11) :3589-3597
[62]   Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells [J].
Wang, Jian-an ;
Chen, Tie-long ;
Jiang, Jun ;
Shi, Heng ;
Gui, Chun ;
Luo, Rong-hua ;
Xie, Xiao-jie ;
Xiang, Mei-xiang ;
Zhang, Xing .
ACTA PHARMACOLOGICA SINICA, 2008, 29 (01) :74-82
[63]   Interleukin-6 contributes to chemoresistance in MDA-MB-231 cells via targeting HIF-1α [J].
Wang, Ke ;
Zhu, Xue ;
Zhang, Kai ;
Yin, Yongxiang ;
Chen, Yu ;
Zhang, Ting .
JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY, 2018, 32 (03)
[64]   NO and hepatocellular cancer [J].
Wang, Ronghua ;
Geller, David A. ;
Wink, David A. ;
Cheng, Bin ;
Billiar, Timothy R. .
BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (24) :5459-5466
[65]   Interplay of long non-coding RNAs and HIF-1α: A new dimension to understanding hypoxia-regulated tumor growth and metastasis [J].
Wang, Xingwen ;
Zhao, Dong ;
Xie, Hui ;
Hu, Ying .
CANCER LETTERS, 2021, 499 :49-59
[66]   Dose dependent effects of cadmium on tumor angiogenesis [J].
Wei, Tianshu ;
Jia, Jin ;
Wada, Youichiro ;
Kapron, Carolyn M. ;
Liu, Ju .
ONCOTARGET, 2017, 8 (27) :44944-44959
[67]   Nitric oxide and redox mechanisms in the immune response [J].
Wink, David A. ;
Hines, Harry B. ;
Cheng, Robert Y. S. ;
Switzer, Christopher H. ;
Flores-Santana, Wilmarie ;
Vitek, Michael P. ;
Ridnour, Lisa A. ;
Colton, Carol A. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2011, 89 (06) :873-891
[68]   Hypoxia Drives Breast Tumor Malignancy through a TET-TNFα-p38-MAPK Signaling Axis [J].
Wu, Min-Zu ;
Chen, Su-Feng ;
Nieh, Shin ;
Benner, Christopher ;
Ger, Luo-Ping ;
Jan, Chia-Ing ;
Ma, Li ;
Chen, Chien-Hung ;
Hishida, Tomoaki ;
Chang, Hong-Tai ;
Lin, Yaoh-Shiang ;
Montserrat, Nuria ;
Gascon, Pedro ;
Sancho-Martinez, Ignacio ;
Izpisua Belmonte, Juan Carlos .
CANCER RESEARCH, 2015, 75 (18) :3912-3924
[69]   Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape [J].
Wu, Qinghua ;
You, Li ;
Nepovimova, Eugenie ;
Heger, Zbynek ;
Wu, Wenda ;
Kuca, Kamil ;
Adam, Vojtech .
JOURNAL OF HEMATOLOGY & ONCOLOGY, 2022, 15 (01)
[70]   P4HA1 is a new regulator of the HIF-1 pathway in breast cancer [J].
Xu, Ren .
CELL STRESS, 2019, 3 (01) :27-28
12345678